The mean of analysts' price targets for Passage Bio (PASG) points to a 731% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

PASG

<p>分析師對 Passage Bio (PASG) 的目標價格均值顯示該股票有 731% 的上漲空間。儘管這一備受關注的指標並未被證明具有合理的有效性，但分析師在提高盈利預期方面的強烈一致性確實表明該股票有上漲的潛力</p>

華爾街分析師認為 Passage Bio（PASG）可能會有 731% 的漲幅：在下注之前請閲讀這篇文章